current user: public

anford Burnham Prebys Medical Discovery Institute
We are hiring bioinformatics experts and software developers. Join us!

Query: 3v2u_C mol:protein length:520 Protein GAL3, from PDB0516

Results of FFAS03 search in PDB0516
Master-slave alignment(slide right to see more) does not show gaps in the query sequence, use ali links to display alignment between query and templates.
    .   10    .   20    .   30    .   40    .   50    .   60    .   70    .   80    .   90    .  100    .  110    .  120    .  130    .  140    .  150    .  160    .  170    .  180    .  190    .  200    .  210    .  220    .  230    .  240    .  250    .  260    .  270    .  280    .  290    .  300    .  310    .  320    .  330    .  340    .  350    .  360    .  370    .  380    .  390    .  400    .  410    .  420    .  430    .  440    .  450    .  460    .  470    .  480    .  490    .  500    .  510    .  520
# Score Template Links and tools%idFirst SNTNVPIFSSPVRDLPRSFEQKHLAVVDAFFQTYHVKPDFIARSPGRVNLIGEHIDYCDFSVLPLAIDVDMLCAVKILDEKNPSITLTNADPKFAQRKFDLPLDGSYMAIDPSVSEWSNYFKCGLHVAHSYLKKIAPERFNNTPLVGAQIFCQSDIPTGGGLSSAFTCAAALATIRANMGKNFDISKKDLTRITAVAEHYVGVNNGGMDQATSVYGEEDHALYVEFRPKLKATPFKFPQLKNHEISFVIANTLVKSNKFETAPTNYNLRVIEVTVAANALATRYSVALPSHKDNSNSERGNLRDFMDAYYARYENQAQPWNGDIGTGIERLLKMLQLVEESFSRKKSGFTVHEASTALNCSREEFTRDYLTTFPVRFQVLKLYQRAKHVYSESLRVLKALKMMTSATFHTDEDFFTDFGRLMNESQASCDKLYECSCIETNQICSIALANGSFGSRLTGAGWGGCTIHLVPSGANGNVEQVRKALIEKFYNVRYPDLTDEELKDAIIVSKPALGTCLYEQLast
1 -157.0003v2u_C mol:protein length:520 Protein GAL3  ali model  100  1SNTNVPIFSSPVRDLPRSFEQKHLAVVDAFFQTYHVKPDFIARSPGRVNLIGEHIDYCDFSVLPLAIDVDMLCAVKILDEKNPSITLTNADPKFAQRKFDLPLDGSYMAIDPSVSEWSNYFKCGLHVAHSYLKKIAPERFNNTPLVGAQIFCQSDIPTGGGLSSAFTCAAALATIRANMGKNFDISKKDLTRITAVAEHYVGVNNGGMDQATSVYGEEDHALYVEFRPKLKATPFKFPQLKNHEISFVIANTLVKSNKFETAPTNYNLRVIEVTVAANALATRYSVALPSHKDNSNSERGNLRDFMDAYYARYENQAQPWNGDIGTGIERLLKMLQLVEESFSRKKSGFTVHEASTALNCSREEFTRDYLTTFPVRFQVLKLYQRAKHVYSESLRVLKALKMMTSATFHTDEDFFTDFGRLMNESQASCDKLYECSCIETNQICSIALANGSFGSRLTGAGWGGCTIHLVPSGANGNVEQVRKALIEKFYNVRYPDLTDEELKDAIIVSKPALGTCLYEQ 520
2 -145.0002aj4_A mol:protein length:548 Galactokinase  ali model follow..  72  21EEVIVPEFNSSAKELPRPLAEKCPSIIKKFISAYDAKPDFVARSPGRVNLIGEHIDYCDFSVLPLAIDFDMLCAVKVLNEKNPSITLINADPKFAQRKFDLPLDGSYVTIDPSVSDWSNYFKCGLHVAHSFLKKLAPERFASAPLAGLQVFCEGDVPTGSGLSSSAAFICAVALAVVKANMGYHMSKQNLMRITVVAEHYVGVNNGGMDQAASVCGEEDHALYVEFKPQLKATPFKFPQLKNHEISFVIANTLVVSNKFETAPTNYNLRVVEVTTAANVLAATYGVVLLSGKEGSSTNKGNLRDFMNVYYARYHNISTPWNGDIESGIERLTKMLVLVEESLANKKQGFSVDDVAQSLNCSREEFTRDYLTTSPVRFQVLKLYQRAKHVYSESLRVLKAVKLMTTASFTADEDFFKQFGALMNESQASCDKLYECSCPEIDKICSIALSNGSYGSRLTGAGWGGCTVHLVPGGPNGNIEKVKEALANEFYKVKYPKITDAELENAIIVSKPALGSCLYE. 541
3 -120.0002a2c_A mol:protein length:478 N-acetylgalactosamine kinase  ali model follow..  32  5SSENLYFQGHMATESPAAEHPRLLKLKEMFNSKFGSIPKFYVRAPGRVNIIGEHIDYCGYSVLPMAVEQDVLIAVEPVKTYALQLANTNPLYP------DFSTSANNIQIDKTKPLWHNYFLCGLKGIQEHFGLS--------NLTGMNCLVDGNIPPSSGLSSSSALVCCAGLVTLTVL-GRNLSKVELAEICAKSERYIGTEGGGMDQSISFLAEEGTAKLIEFSP-LRATDVKLPS----GAVFVIANSCVEMNK--AATSHFNIRVMECRLAAKLLAKYKSLQWDKVLRLEEVQ----------------------------AKLGISLEEMLLVTEDALHPEPYNPEEICRCLGISLEELRTQILSPNTQDVLIFKLYQRAKHVYSEAARVLQFKKICEE----APENMVQLLGELMNQSHMSCRDMYECSCPELDQLVDICRKFGAQGSRLTGAGWGGCTVSMVPA---DKLPSFLANVHKAYYQRS--DGSLAPEKQSLFATKPGGGALVLLE 471
4 -90.4001wuu_A mol:protein length:399 Galactokinase  ali model follow..  28  8................PQVAELLAEARRAFREEFGAEPELAVSAPGRVNLIGEHTDYNQGLVLPMALELMTVLVGSPRKDGLVSLLTTSEGAD-EPQRLQFPLPTAQRSLEPGTPRWANYVKGVIQYYPA------------APLPGFSAVVVSSVPLGGGLSSSASLEVATYTFLQQL-CPDSGTIAARAQVCQQAEHFAGMPCGIMDQFISLMGQKGHALLIDC----RSLETSLVPLSDPKLAVLITNSNV---RHSLASSEYPVRRRQCEEVARALG------KESLREVQLEELEAARDLVSKE------------------------------------------------------------------------GFRRARHVVGEIRRTAQAAAALRRGD-------YRAFGRLMVESHRSLRDDYEVSCPELDQLVEAALAPGVYGSRMTGGGFGGCTVTLLEA---SAAPHAMRHIQEHY-----------GGTATFYLSQAADGAKVLC. 392
5 -88.0001pie_A mol:protein length:419 Galactokinase  ali model follow..  25  20.................ENSTVLSALTEKFAEVFGDTKEVYFFSPGRINLIGEHTDYNGGYVFPASITIGTTGLARLREDKKVKLYSENFPKL---GVIEFDLDEVEKK---DGELWSNYVKGMIVMLKGAGYEID---------KGFELLIKGEIPTASGLSSSASLELLVGVVLDDL-FNLNVPRLELVQLGQKTENYIGVNSGILDQFAIGFGEVKKAIELDCN----TLKYEMVPVELRDYDIVIMNT---NKPRALTESKYNERFAETREALKRMQTRLDIQ-------------------------------------------------------------------------SLGELSNEEFDANTDLIGDETLIKRARHAVYENNRTKIAQKAFVAGN-------LTKFGELLNASHASLKDDYEVTGLELDTLAETAQKAGVLGARMTGAGFGGCAIALVAH---DNVSAFRKAVGQVYEEV-------VGYPASFYVAQIGSGSTKLDV 412
6 -86.1001s4e_A mol:protein length:352 Galactokinase  ali model follow..  25  2.....................................SKITVKSPGRVNLIGEHTDYTYGYVMPMAIDLYTIITAEKYDK--VQLYSEHFNEEKTFTLDNLT----------KEGSWIDYVKGVLWVLIQ----------EGYKIGGLKGKITGDLPLGAGLSSSASFEVGILEVLNQL-YNLNIDPLKKALLAKKAENFVGVPCGILDQFAVVFGKKDNVIFLDT----QTLQYEYIPFP-KDVSVLVFYTGV---KRELASSEYAERKRIAEESLRILG------KESSKEVTEKDLGKLPPL----------------------------------------------------------------------------HRKFFSYIVRENARVLEVRDALKEGD-------IEKVGKILTTAHWDLAENYRVSCEELDFFVKKAMELGAYGARLTGAGFGGSAIALVDK---DKAKTIGDAILREYLAK-------FSWKAKYFVVKPSDGVGV... 352
7 -85.6002cz9_A mol:protein length:350 Probable galactokinase  ali model follow..  24  3........................................KVKSPGRVNLIGEHTDYTYGYVMPMAINLYTKIEAEKHGE--VILYSEHFGEERKFSLNDLR----------KENSWIDYVKGIFWVLKE----------SDYEVGGIKGRVSGNLPLGAGLSSSASFEVGILETLDKL-YNLKLDSLSKVLLAKKAENFVGVPCGILDQFAVVFGREGNVIFLDT----HTLDYEYIPFP-KDVSILVFYTGV---RRELASSEYAERKHIAEESLKILG------KGSSKEVREGELSKLPPL----------------------------------------------------------------------------HRKFFGYIVRENARVLEVRDALKEGN-------VEEVGKILTTAHWDLAKNYEVSCKELDFFVERALKLGAYGARLTGAGFGGSAIALVDK---EDAETIGEEILREYLKR-------FPWKARHFIVEPSDGVGI... 350
8 -45.8001kkh_A mol:protein length:317 Mevalonate Kinase  ali model follow..  21  3....................................GSHMIIETPSKVILFGEHAVVYGYRAISMAIDLTSTIEIKETQEDEIILNLNDLNKSLGLNLNEIK------NINPNNFGDFKYCLCAIKNTLDYL--------NIEPKTGFKINISSKIPISCGLGSSASITIGTIKAVSGF-YNKELKDDEIAKLGYMVEKEIQGKASITDTSTITYKG----ILEIKNNKFRKIKGEFEEFLKNCKFLIVYAEKRKKKTAELVNE-------------------------------------------------------------------------------------------------------------------VAKIENKDEIFKEIDKVID---------EALKIKNKEDFGKLMTKNHELLKK-LNISTPKLDRIVDIGNRFG-FGAKLTGAGGGGCVIILVNE---EKEKELLKELNKEDVRI............................ 310
9 -45.6001vis_A mol:protein length:324 Mevalonate kinase  ali model follow..  20  2......................................SLIIETPSKVILFGEHAVVYGYRAISMAIDLTSTIEIKETQEDEIILNLNDLNKSLGLNLNEIK------NINPNNFGDFKYCLCAIKNTLDYL--------NIEPKTGFKINISSKIPISCGLGSSASITIGTIKAVSGF-YNKELKDDEIAKLGYMVEKEIQGKASITDTSTITYKG----ILEIKNNKFRKIKGEFEEFLKNCKFLIVYAEKRKKKTAELVNE-------------------------------------------------------------------------------------------------------------------VAKIENKDEIFKEIDKVID---------EALKIKNKEDFGKLMTKNHELLKK-LNISTPKLDRIVDIGNRFG-FGAKLTGAGGGGCVIILVNE---EKEKELLKELNKEDVRIFNCRMMNEGGS................. 318
10 -45.0004hac_A mol:protein length:321 Mevalonate kinase  ali model follow..  21  11..................................RGSHMVSCSAPGKIYLFGEHAVVYGETAIACAVELRTRVRAELNDSITIQSQIGRTG----------------------DFEKHPYVSAVIEKMRKSIPI-----------NGVFLTVDSDIPVGSGLGSSAAVTIASIGALNEL-FGFGLSLQEIAKLGHEIEIKVQGAASPTDTYVSTFG---GVVTIPERRKLKTPDCGI----------VIGDTGVFSSTKELVANVRQLRESYPDLIEPLMT--------------------------------------------------------------------------------------------------------------------SIGKISRIGEQLVLSGDYASIGRLMNVNQ-GLLDALGVNILELSQLIYSARAAGAFGAKITGAGGGGCMVALTAPEKCNQVAEAVAGAGGK----------------VTITKPTEQGLKV... 314
11 -44.7002oi2_A mol:protein length:292 Mevalonate kinase  ali model follow..  16  2...................................TKKVGVGQAHSKIILIGEHAVVYGYPAISLPLLEVEVTCKVVPAESPWRLY-----------------------------EEDTLSMAVYASLEYL----------NITEACIRCEIDSAIPEKRGMGSSAAISIAAIRAVFDY-YQADLPHDVLEILVNRAEMIAMNPSGLDAKTCLSDQ------PIRFIKNVGFTELEMDL----SAYLVIADTGVYGH---TREAIQVVQNKGKD--------------------------------------------------------------------------------------------------------------ALPFLHALGELTQQAEIAISQKD-------AEGLGQILSQAHLHLKE-IGVSSLEADSLVETALSHGALGAKMSGGGLGGCIIALVTNL--THAQELAERLEEKGAVQ............................ 286
12 -43.1002hfs_A mol:protein length:332 Mevalonate kinase, putative  ali model follow..  17  2...........................SHMSKPVKSKTTGKNIGYGKVILFGEHFVVHGAEAIVAGISEYTECRLEINPGVP-----------------GLQVDDQRPAIPGYIAQKRDEQIKAHQLVLDHLKVDLSGD-------GLKMFIGGPLVPSSGIGASASDVVAFSRALSEL-YQLNLTDEEVNLSAFVGEGGYHGTPSGADNTAATYG--GLILYRRQNGKSVFKPIAFQQ----RLYLVVVGTGINASTAKVVNDVHKMKQQQPVQFKRLYD--------------------------------------------------------------------------------------------------------------------NYTHIVSQAREALQKGDLQRLGQLMNANHDLCRQ-IDVSCRELESIVQTCRTYGALGAKLSGTGRGGIAVALAASS--DQRDAIVKGLKAKCPEAKFIW----------YTVQPSAASNL... 332
13 -39.5004n3o_A mol:protein length:342 Putative D-glycero-D-manno-heptose 7-phosphat  ali model follow..  14  7.......................................IRTQTPLRLGLAGGGTDIYTGYVLNATISLYIHCTLIKREDGKIIFDSPDTNSYCEYESKE----------FLGNDGKLDIFKSIYNRIVKDFTKKP---------LSFSLHTYSDVPSGSGLGGSSTLVVGV-IKAFAEWLNLPLGEYEIAKLAYEIERDLGIVGGAQDQYAATFGGFNFMEFYN-NKRVIVNPLRI----------------------------KNWIASELEARTVLYFTNITREAKDIEEHKKGKLGDEKSL----------------------------------------------------------------------------------------EAMHAIKQDAIKMKEALFRADFGTLAQILGKSWRSKKIISEVSNDELERIYKLAIDNGAYSGKTSGAGAGGFMFFFVDPTKKYNLIKALRKEQGYVQDFSFTK----------------EGVKSWR. 341
14 -34.9002x7i_A mol:protein length:308 MEVALONATE KINASE  ali model follow..  17  4....................................TRKGYGESTGKIILIGEHAVTFGEPAIAVPFNAGKIKVLIEALESGNYSSIKS-------------------VYDGMLYDAPDHLKSLVNRFVELNNITE----------PLAVTIQTNLPPSRGLGSSAAVAVAFVRASYDF-LGKSLTKEELIEKANWAEQIAHGKPSGIDTQTIVSGK---PVWFQKGHAETLKTLSL------DGYMVVIDTGVKGSTRQAVHD-----------------------------------------------------------------------------------------------------------------------HKLCEDPQYMSHVKHIGKLVLRASDVIEHHKFEALADIFNECHADLKA-LTVSHDKIEQLMKIGKENGAIAGKLTGAGRGGSMLLLAKDL--PTAKNIVKAVEKA................................ 296
15 -34.6002r3v_A mol:protein length:396 Mevalonate kinase  ali model follow..  17  3....................................SEVLLVSAPGKVILHGEHAVVHGKVALAVSLNLRTFLRLQPHSNGKVDLSLPNIGIKRAWDVARLQSLDTSFLEQGDVTTPTSEQVEKLKEVAGLPDDCAVTERKQRALPSLDIVVWSELPPGAGLGSSAAYSVCLAAALLTVCEEIKEDLELINKWAFQGERMIHGNPSGVDNAVSTWGHQGKISSLKRSPALQ---------------ILLTNTKVPRNTRALVAGVRNRLLKFPEIVAPLLTSIDAI-------------------------------------------------------------------------------------------------------------SLECERVLGEMGEAPAPEQYLVLEELIDMNQHHLNA-LGVGHASLDQLCQVTRARG-LHSKLTGAGGGGCGITLLKPGLEQPVEATKQALTSCGFDCLETSIGAPGVS................. 378
16 -34.6001kvk_A mol:protein length:395 mevalonate kinase  ali model follow..  17  3....................................SEVLLVSAPGKVILHGEHAVVHGKVALAVALNLRTFLVLRPQSNGKVSLNLPNVGIKQVWDVATLQLLDTGFLEQGDVPAPTLEQLEKLKKVAGLPRDCVGNERKQRTLPSLDIMVWSELPPGAGLGSSAAYSVCVAAALLTACEEVEEDLKSINKWAYEGERVIHGNPSGVDNSVSTWGQQGKMSSLKRLPALQ---------------ILLTNTKVPRSTKALVAGVRSRLIKFPEIMAPLLTSIDAI-------------------------------------------------------------------------------------------------------------SLECERVLGEMAAAPVPEQYLVLEELMDMNQHHLNA-LGVGHASLDQLCQVTAAHG-LHSKLTGAGGGGCGITLLKPGLEAKVEAAKQALTGCGFDCWETSIGAPGVS................. 378
17 -28.5003k17_A mol:protein length:365 Lin0012 protein  ali model follow..  11  4....................................KNKLQVKIPGKLYVAGEYVVESGHTAILTAVNRYITLTLEDSERNELWIPH-----------YENPVSWPIGGELKPDGEHWTFTAEAINIATTFLKSEGIELTP----MVIETELIDQSGAKYGLGSSAAATVAVINALMTK-FYPEISMLKKFKLAALSHLVVQGNGSCGDIASCMYGTFDQEWVKHRLAYKSLEWFQIETLEEPVPTFSVGWTGTPVSTGKLVSQIHAFKQEDSKNYQHFLT--------------------------------------------------------------------------------------------------------------------RNNEIMKQIIQAFHTKDEELLYSSIKENRRILQEGVNIETSLLKELADSAENMGG-AGKSSGSGGGDCGIAFSKTK--ELAEKLVNEWEKLGIKHLPFHTGRVQITEG............... 359
18 -28.4004usk_A mol:protein length:346 PUTATIVE SUGAR KINASE  ali model follow..  17  6.......................................IRARAPLRLGLAGGGTDVFGGYVLNATIDRYAYAVIKTLTIPAVRFVSTDQQVEKHQLISEPLELNGTLNLHKA------------------VYNHMIRNYNHGKPIALELSTFCDAPAGSGLGSSSTLVVVM-IKAFVELLNLPLDDYAIAQLAYRIERDCGLAGGRQDQYSATFG----FNFMEFYAAVNPLRIKNWVLCELEASLVLFYTGVSRESAKIIQDQSDNVVSHKTAAIEAMH--------------------------------------------------------------------------------------------------------------------GIKREALVMKEALLKGDFKAFVASMRLGWDNKKNSARVSNAHIDEIYDAAIRAGAQAGKVSGAGGGGFMLFFVPTEKRMDLIRTLGEYDGQVSNCHFTK........................ 336
19 -28.1003k85_A mol:protein length:357 D-glycero-D-manno-heptose 1-phosphate kinase  ali model follow..  15  4.......................................VRSKAPLRLGLAGGGSDVYGGLILNATINLYAYCTIEETNSGRIEINAYDAQCCKSYLSMSQLEIDGEASLIKGVY-------------------NRIIRDYRLEPKSFKITTYNDAPAGSGLGTSSTMVVCI-LKAFIEWLSLPLGDYETSRLAYEIER-LGLSGGKQDQYAAAFG----FNYMEFLQNVNPLKMKRWIVDELESSMVLYFTGRSRSSAAIINEQKKNTSEGNQTAIEAMH--------------------------------------------------------------------------------------------------------------------KIKQSAIDTKLALLKGDVGEFARILGEGWENKKKMAGITNPMIQEAFDVATGAGAMAGKVSGAGGGGFIMFVVEPTRKEEVVRALNNLNGFVMPFQFID........................ 333
20 -28.0001k47_A mol:protein length:337 phosphomevalonate kinase  ali model follow..  11  5........................................AVKTCGKLYWAGEYILEPGQLALIKDIPIYMRAEIAFSDSYRIYSDMFDFA------------------VDLRPNPDYSLIQETIALMGDFLAVR------GQNLRPFSLAIYGKMEREGGLGSSGSVVVLVVKALLAL-YNLSVDQNLLFKLTSAVLLKRGDNGSMGDLACIAAEDRQKVAAWLEEENLATVLERDWGFSISQVKPTLECDFLVGWTKEVAVSSHMVQQIKQNINQNFLT--------------------------------------------------------------------------------------------------------------------SSKETVVSLVEALEQGKSEKIIEQVEVASKLLEGLSTDIYTPLLRQLKEASQDLQAVAKSSGAGGGDCGIALSFDA--QSTKTLKNRWADL................................ 321
21 -14.3004p52_A mol:protein length:331 Homoserine kinase  ali model follow..  17  23.........................................VFAPATVANVSCGFD-----VLGFAVDNGDEVLLRLSDKKGVRITSITGDDG------RLPKDAEK-----------NTVSISILRYLETL----------GIEQGIEIELTKKMPLGSGLGSSAASTVA-GVYAINQLLGNKMEVKDLLPFAMEGEFLAC-GSAHADNVAPCL---GGFVLVRSYDPLDVVKLPVPA----NLYATIIHPHVE---------------VQTKDARNILPKQIALS----------------------------------------------------------------------------------------------------QAVAQWGNVGGLVAGLLMNDTSLIGRSMQD--HIVEPARSVL-------IPGFDDVKKAALDAGALGCSISGSG---SIFALSTS--QEAAQKIGQAMKKGF--------DAINIGSDVYVSTVNQGPKVI.. 325
22 -12.8004rpf_A mol:protein length:310 Homoserine kinase  ali model follow..  13  5.........................................IYAPASIGNVSVGFD-----VLGAAVSLGDCVSVTAAERFSLHNEGRFVS--------KLPDDPKQ-----------NIVYQCWERFCQEM----------GKEIPVAMVLEKNMPIGSGLGSSACSVVA-GLMAMNEFCGQPLDKVTLLGMMGELE---GRVSGSIDNVAPCY---GGMQLILEQEGYISQDVPGFS----DWLWVMAYPGIK---------------VSTAEARAILPAQYRR----------------------------------------------------------------------------------------------------QDCITHGRNLAGFIHACHTQQPDLAAKMMKDV----------IAEPYRTQLPGFAAARQAAQDIGALACGISGSG---TLFAVCND--QATAQRMAGWLQNHYLQNDEGFVHICRLDT--------AGARLL.. 309
23 -12.4001fwk_A mol:protein length:296 HOMOSERINE KINASE  ali model follow..  13  2......................................KVRVKAPCTSANLGVGFD-----VFGLCLKE--VIEVEAIDDKEIIIEVDDKNIPTDPDK--------------------NVAGIVAKKMIDDF----------NIGKGVKITIKKGVKAGSGLGSSAASSAG-TAYAINELFKLNLDKLKLVDYASYGELASSGA-KHADNVAPAI---GGFTMVTNYEPLEVLHIPIDF----KLDILIAIPNIS---------------INTKEAREILPKAVGLK----------------------------------------------------------------------------------------------------DLVNNVGKACGMVYALYNKDKSLFGRYMMS-DKVIEPVRGKLIPNYF---------IKEEVKDKVYGITISGSG---SIIAFPKEEFIDEVENILRDYYENT-----------------IRTEVGKGVEVV.. 296
24 -12.3001oj4_A mol:protein length:283 4-DIPHOSPHOCYTIDYL-2-C-METHYL-D-ERYTHRITOL KI  ali model follow..  18  7...........................................SPAKLNLTGQRADYHTLQTLFQFLDYGDTISIELRDDGDIRLLTPVEGVEHEDNL--------------------------IVRAARLLMKTAADSGRLPTGSGANISIDKRLPMGGGLGGGSS-NAATVLVALNHLWQCGLSMDELAEM--------GLTLGA-DVPVFVRGHAAFA---------EGVGEILTPVDPPEKWYLVAHPGVSIPTPVIFKDPELPRNTPKRSIETLLKCEFSNDCEVI..................................................................................................................................................................................................................................... 214
25 -11.0003hul_A mol:protein length:298 Homoserine kinase  ali model follow..  16  2......................................SLRIRVPATTANLGPGFDSCG-----LALTLYLTLDIGAEADS---------------------WYIEHNIGGGIPHDETNVIIETALNLAP-------------NLTPHHLVMTCDIPPARGLGSSSAAVVA-GIELANTLAELNLSKEEKVRIAAEIE-------GHPDNVAPAV-----NWVVGAKLDGEDFYVRHLFPDCALIAFIPKAELLTSESRGVLPDTLPFKEAVQASSIANV-------------------------------------------------------------------------------------------------------------------------------AAILRNDMTLAGEMMERDL--WHEKYRSQVPHLAQIRDVAKNQGAYAACLSGAG---TVLVFAPRNLANKLQTSLQTLEIDA--------------DVLLLDVEGSGAEVFRE 291
26 -10.8003pyd_A mol:protein length:306 4-diphosphocytidyl-2-C-methyl-D-erythritol ki  ali model follow..  17  5......................................SVTVRVPGKVNLGDRREDYHELTTVFHAVSLVDEVTVRNADVLSLELVGEGAD--------QLPTDERNLAWQAAELMAEHV----------------------GRAPDVSIMIDKSIPVAGGMAGGSA-DAAAVLVAMNSLWELNVPRRDLRMLAAR----LGS-----DVPFALHG--GTALGTGRGEELATVL------SRNTFHWVLA----FADSGLLTSAVYNE--------------------------------------------------------------------------------------------------------------------DRLREVGDPPRLGEPGPVLAALAAGDPDQLAPLLGNEMQAAAVSLD-------PALARALRAGVEAGALAGIVSGSG----TCAFLCTS-ASSAIDVGAQLSGA-------------CRTVRVATGPVPGARVVSA 302
27 -10.7004dxl_A mol:protein length:318 4-diphosphocytidyl-2-C-methyl-D-erythritol ki  ali model follow..  17  17......................................AVTVRAPGKVNLGDLRDDYHELTTVFHAVSLADDVTVRDADVLSIDVVGQGEG--------TVPTDERNLAWQAAELFADHV----------------------GRAPDVSIFINKDIPVAGGMAGGSA-DAAAVLVAMNELWHAGVPRRDLHHLAAQ----LGS-----DVPFALHG--GTALGTGRGEQLATVL------ARNVFHWVFAFA---------------------------------------------------------------------------------------------DGGLATPQVFKEIDRLREN--------------------------GDPPRLAEADELLGALAAGDARRLAPLLGNELQAAAVSLN-------PELRRTLRAGESAGALAGIVSGSG----TCAFLCTS-ADDAVQVSAELAGA-------------CRTVRVASGPVHGAQVIQ. 313
28 -9.5902v2q_A mol:protein length:271 4-DIPHOSPHOCYTIDYL-2-C-METHYL-D-ERYTHRITOL KI  ali model follow..  15  7.........................................VLSPAKINLLGRLPSYHEILTLYQEIPFY--------------------------DEIYIREGVLRVETNIGIPQEENLVYKGLREFERIT----------GIEINYSIFIQKNIPPGAGLGGGSS-NLAVVLKKVNELLGSPLSEEELRELVGS----ISADGRGKGEVLEPVETEISGKITLVIPQVSSSTGRV........................................................................................................................................................................................................................................................................................... 177

FFAS is supported by the NIH grant R01-GM087218-01
1 1 6 5 6 4   jobs submitted since Jan 1, 2011
Comments and questions to: webmaster

Selected papers from Godzik Lab
Ying Zhang, Ines Thiele, Dana Weekes, Zhanwen Li, Lukasz Jaroszewski, Krzysztof Ginalski, Ashley Deacon, John Wooley, Scott Lesley, Ian Wilson, Bernhard Palsson, Andrei Osterman, Adam Godzik. Three-Dimensional Structural View of the Central Metabolic Network of Thermotoga maritima. Science. 2009 Sep 18;325(5947):1544-9.

Alexey M. Eroshkin, Andrew LeBlanc, Dana Weekes, Kai Post, Zhanwen Li, Akhil Rajput, Sal T. Butera, Dennis R. Burton, Adam Godzik. bNAber: database of broadly neutralizing HIV antibodies. Nucl. Acids Res. 2013; published on November 7, 2013.

Jaroszewski L, Rychlewski L, Zhang B, Godzik A. Fold prediction by a hierarchy of sequence, threading, and modeling methods. Protein Sci. 1998 Jun;7(6):1431-40.